Overview
The Gut-Brain Axis in Cirrhosis Laboratory led by Patty P. Bloom, M.D., studies hepatic encephalopathy, a complication of cirrhosis that can affect thinking, behavior, movement and daily functioning. The lab studies how changes in the intestine, liver and brain contribute to these symptoms and why some people develop recurrent episodes.
Much of the lab's work focuses on the gut microbiome — the community of bacteria in the digestive tract — and the intestinal barrier. The team combines clinical information with stool, blood and tissue and follows participants over time. The goal is to identify features associated with later hepatic encephalopathy so that we can develop better therapies targeted at treating this illness.
The lab also studies gut-directed treatments, including diet, special bacterial therapies and medicines used to treat hepatic encephalopathy. These studies measure the microbiome, intestinal function and cognition to understand how treatments work and identify approaches that merit larger trials.
Other projects evaluate speech recordings, cognitive testing, brain imaging and digital tools as possible ways to detect or track changes in the disease. The lab also collaborates on animal experiments to study gut-related mechanisms under controlled conditions.
By linking patient outcomes with microbiome, intestinal and neurologic measurements, the lab seeks to improve how hepatic encephalopathy is predicted, recognized and treated within Mayo Clinic's Division of Gastroenterology and Hepatology.
Dr. Bloom's lab collaborates with Madhusudan Grover, M.B.B.S., and Aaron L. Hecht, M.D., Ph.D. — both from Mayo Clinic.